Qube Research & Technologies LTD Angion Biomedica Corp. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.94 - $1.23 $1,212 - $1,586
-1,290 Reduced 8.26%
14,330 $13,000
Q2 2022

Aug 15, 2022
BUY
$1.1 - $2.23 $17,182 - $34,832
15,620 New
15,620 $18,000
Q1 2022

May 09, 2022
SELL
$1.72 - $2.96 $19,625 - $33,773
-11,410 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$2.35 - $9.95 $26,813 - $113,529
11,410 New
11,410 $33,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email